Skip to main content
logo
Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.330
-0.010 (-0.75%)
At close: Aug 1, 2025, 4:00 PM
1.370
+0.040 (3.01%)
After-hours: Aug 1, 2025, 7:06 PM EDT

MorphoSys AG Revenue

Organigram Global had revenue of 65.60M CAD in the quarter ending March 31, 2025, with 74.34% growth. This brings the company's revenue in the last twelve months to 194.09M, up 20.49% year-over-year. In the fiscal year ending September 30, 2024, Organigram Global had annual revenue of 159.84M with 7.13% growth.

Revenue (ttm)
194.09M CAD
Revenue Growth
+20.49%
P/S Ratio
1.33
Revenue / Employee
216,134 CAD
Employees
898
Market Cap
179.49M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2024159.84M10.64M7.13%
Sep 30, 2023149.21M3.40M2.33%
Aug 31, 2022145.81M66.65M84.19%
Aug 31, 202179.16M-7.63M-8.79%
Aug 31, 202086.80M6.38M7.94%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings

OGI News

More News